Literature DB >> 2583238

Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice.

M J Durcan1, P F Morgan.   

Abstract

The hypomobility induced by a series of adenosine analogues was investigated using a holeboard test and their behavioral potencies correlated to their reported adenosine A1 and A2 receptor affinities. All of the adenosine analogues dose dependently inhibited both exploratory behavior (head dipping) and locomotor activity. The rank order of potency 5'-ethylcarboxamido adenosine (NECA) greater than 5'-methylcarboxamido adenosine (MECA) greater than N6-[(R)-1-methyl-2-phenylethyl]adenosine (R-PIA) greater than N6-cyclohexyladenosine (CHA) = N6-cyclopentyladenosine (CPA) greater than N6-[(S)-1-methyl-2-phenylethylladenosine (S-PIA) greater than N6-(2-hydroxyethyl)adenosine (2-OH-ethyl) was observed for inhibiting both activities. The behavioral potency of these adenosine analogues correlates extremely well with their reported A2 receptor affinity (r2 = 0.93, P less than 0.01 and r2 = 0.86, P less than 0.05 for locomotor and head dipping activity respectively), but very poorly with their reported A1 receptor affinity (r2 less than 0.02, P greater than 0.50 for both activities). These results suggest that adenosine A2 receptors, but not A1 receptors, may be involved in the hypomobility induced by adenosine analogues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583238     DOI: 10.1016/0014-2999(89)90789-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats.

Authors:  S Satoh; H Matsumura; F Suzuki; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion.

Authors:  K Plaschke; M Grant; M A Weigand; J Züchner; E Martin; H J Bardenheuer
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 3.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

4.  Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs.

Authors:  G B Kaplan; M T Sears
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

5.  The role of adenosine receptors in the central action of caffeine.

Authors:  John W Daly; Dan Shi; Olga Nikodijevic; Kenneth A Jacobson
Journal:  Pharmacopsychoecologia       Date:  1994

6.  Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.

Authors:  S Ferre; G von Euler; B Johansson; B B Fredholm; K Fuxe
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 7.  Mental Fatigue Impairs Endurance Performance: A Physiological Explanation.

Authors:  Kristy Martin; Romain Meeusen; Kevin G Thompson; Richard Keegan; Ben Rattray
Journal:  Sports Med       Date:  2018-09       Impact factor: 11.136

8.  FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity.

Authors:  Marc Flajolet; Zhongfeng Wang; Marie Futter; Weixing Shen; Nina Nuangchamnong; Jacob Bendor; Iwona Wallach; Angus C Nairn; D James Surmeier; Paul Greengard
Journal:  Nat Neurosci       Date:  2008-10-26       Impact factor: 24.884

9.  Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.

Authors:  O Nikodijević; R Sarges; J W Daly; K A Jacobson
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

10.  Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease.

Authors:  M Morelli; J Wardas
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.